phase 2_completion
saveClostraBio Inc — CLB-101 (Phase II Trial Completion)
community read0 votes
Therapy area: Gastrointestinal, Metabolic Disorders. Indication: Obesity, Overweight, Unspecified Gastrointestinal Disorders
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that